Drugs giants must help to solve the antibiotics crisis

  03 February 2020

It has been four decades since we’ve had a new class of antibiotics. Yet across the world, the number of people suffering from drug-resistant infections continues to rise at an alarming rate.

Without new antibiotics, blood poisoning, gonorrhoea and urinary tract infections, to name just three, risk becoming untreatable. More people will suffer fatal complications from routine medical procedures like chemotherapy or organ transplants. But the prospects for new treatments are more fragile than ever.

This month there has been a surge in reports on the issue. The World Health Organisation warned that there are too few drugs in the pipeline to deal with the growing threat of drug resistance. 

Further reading: The Times
Author(s): Tim Jinks
Effective Surveillance  
Back


Boosting innovation in AMR?

15 OCT 2020: online Kick Off event AMR Innovation Mission UK 2021

 

The AMR Innovation Mission UK 2020/2021 aims to add to the global curbing of AMR by boosting joint early & translational research, R&D, clinical development,  validation, registration and commercialisation of vaccines, microbial diagnostics and antimicrobial products.

 

Register today >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!